Screening of Antianxiety Activity of Habenaria Intermedia D. Don Fruits
Journal Title: JOURNAL OF PHARMACEUTICAL TECHNOLOGY, RESEARCH AND MANAGEMENT - Year 2017, Vol 5, Issue 1
Abstract
Habenaria intermedia D. Don (Vriddhi; Orchidaceae) has been traditionally used in the treatment of nervous disorders, skin disorders and asthma. The available pharmacological reports on H. intermedia reveal that the plant has not been screened for antianxiety activity. Thus, it was envisaged to subject H. intermedia for screening of antianxiety activity using elevatedplus maze model. The crude extracts (n-hexane, chloroform, methanol and water extracts) of plant material were prepared successively in increasing order of polarity. The anxiolytic activity was assessed by comparing number of entries and average time spent by mice treated with test extracts (200 or 400 mg/kg, p.o.) in open arms of EPM with respect to control and standard drug, diazepam (2 mg/kg, p.o.). Significant antianxiety activity was observed in methanol extract with respect to control, whereas n-hexane, chloroform and water extracts did not exhibit antianxiety activity. It is further observed that antianxiety activity exhibited by the methanol extract was statistically not equivalent to the standard drug. Based on these observations, it is concluded that the methanol extract of H. intermedia exhibits mild anxiolytic activity.
Authors and Affiliations
Pawan Kumar , Reecha Madaan , Shabir Sidhu
An Update on Some Recent Solubility Enhancers as Pharmaceutical Excipients
At present the pharmaceutical academia and industries are focusing on the use of natural materials and resources for development of pharmaceutical product. Due to advances in drug delivery technology, currently, excipien...
Anxiolytic activity of Angiotensin-Receptor-Blocker in Experimental Models of Anxiety in Mice
The present study aimed to explore the role of Angiotensin- Receptor-Blocker in the management of anxiety. Male Swiss albino mice of age 6-8 weeks and weight 25-30 g were used in the present study. Candesartan (Angiotens...
Development And Characterization of Inhaled Chitosan Nanoparticles Loaded with Isoniazid
The objective of our study is to load first line anti-tubercular drug, Isoniazid in chitosan Nanoparticles in order to enhance bioavailability and to reduce dose frequency. The chitosan nanoparticles containing the drug...
Traditional and Novel Herbal Drugs Emerging as Potent Novel Combinations for Managing Morbidities by Pharmacological and Mechanistic Studies
Background: Herbal drugs are used in treatment of diseases since decades. Major contributing factor for their use is easy availability, less expensive and more belief of common population because of relatively less side...
Molecular Docking Evaluation of Some Natural Phenolic Compounds as Aldose Reductase Inhibitors for Diabetic Complications
The enzyme aldose reductase (AR) is a member of aldoketoreductase super-family which catalyzes the formation of sorbitol from glucose through polyol pathway of glucose catabolism. Reduced sorbitol production via polyol p...